Cargando…
A Retrospective Analysis of the Clinical Outcomes of Leptomeningeal Metastasis in Patients with Solid Tumors
BACKGROUND: Leptomeningeal metastasis (LM) is an uncommon, but devastating complication of advanced cancer and has no standard treatment. Herein, we analyzed the clinical characteristics and outcomes of patients with solid tumors who were diagnosed with LM. METHODS: Between January 2007 and December...
Autores principales: | Kim, Hyojeong, Lee, Eun Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212684/ https://www.ncbi.nlm.nih.gov/pubmed/30381917 http://dx.doi.org/10.14791/btrt.2018.6.e12 |
Ejemplares similares
-
Leptomeningeal metastasis from solid tumors: clinical features and its diagnostic implication
por: Pan, Zhenyu, et al.
Publicado: (2018) -
Development of Two Diagnostic Prediction Models for Leptomeningeal Metastasis in Patients With Solid Tumors
por: Gao, Tianqi, et al.
Publicado: (2022) -
Impact of Multimodality Approach for Patients with Leptomeningeal Metastases from Solid Tumors
por: Kwon, Jeanny, et al.
Publicado: (2014) -
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
por: Naidoo, Jarushka, et al.
Publicado: (2021) -
LPTO-09. INTRATHECAL TOPOTECAN FOR LEPTOMENINGEAL METASTASIS IN SOLID TUMORS: THE MD ANDERSON EXPERIENCE
por: Sinicrope, Kaylyn D, et al.
Publicado: (2019)